419825 Sigma-AldrichHh Signaling Antagonist X, Itraconazole - CAS 84625-61-6 - Calbiochem
The Hh Signaling Antagonist X, Itraconazole, also referenced under CAS 84625-61-6, controls the biological activity of Hh pathway. This small molecule/inhibitor is primarily used for Cell Signaling applications.
More>> The Hh Signaling Antagonist X, Itraconazole, also referenced under CAS 84625-61-6, controls the biological activity of Hh pathway. This small molecule/inhibitor is primarily used for Cell Signaling applications. Less<<Synonyms: 14LDM Inhibitor, Oriconazole, R51211, Smo Antagonist VII, Sporanox, 14-α-demethylase Inhibitor
Recommended Products
Overview
| Replacement Information | 
|---|
Key Spec Table
| CAS # | Empirical Formula | 
|---|---|
| 84625-61-6 | C₃₅H₃₈Cl₂N₈O₄ | 
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 419825-250MG | 
  |  
Glass bottle | 250 mg | 
  | 
— | 
| Description | |
|---|---|
| Overview | A cell-permeable, orally available triazole-class antifungal agent that, in addition to its known inhibitory activity against fungal cytochrome P450 14-α-demethylase, also acts as an effective Hh signaling inhibitor (IC50 ~ 0.8 µM against SHHN-induced Gli transcription activity in Shh-Light2 cells) in a Ptch-independent manner (IC50 ~ 0.9 µM against Ptch promoter-mediated transcription activity in murine Ptch-/- fibroblasts), presumably by binding smoothened (smo) at a site distinct from that targeted by cyclopamine (Cat. No. 239803) and SAG (Cat. No. 566660), as Itraconazole does not compete with BODIPY-cyclopamine binding, and it alters only the magnitude, but not the EC50, of SAG-induced Gli transcription activity in Shh-Light2 cells. Shown to effectively suppress Hh pathway-dependent growth of both engrafted medulloblastoma and endogenous basal cell carcinoma in mice in vivo (37.5 to 100 mg/kg/12 hr, p.o.) in a reversible manner. | 
| Catalogue Number | 419825 | 
| Brand Family | Calbiochem® | 
| Synonyms | 14LDM Inhibitor, Oriconazole, R51211, Smo Antagonist VII, Sporanox, 14-α-demethylase Inhibitor | 
| References | |
|---|---|
| References | Kim, J., et al. 2010. Cancer Cell 17, 388. | 
| Product Information | |
|---|---|
| CAS number | 84625-61-6 | 
| Form | White powder | 
| Hill Formula | C₃₅H₃₈Cl₂N₈O₄ | 
| Chemical formula | C₃₅H₃₈Cl₂N₈O₄ | 
| Structure formula Image | |
| Quality Level | MQ100 | 
| Applications | 
|---|
| Biological Information | |
|---|---|
| Purity | ≥98% by HPLC | 
| Physicochemical Information | 
|---|
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | |
|---|---|
| R Phrase | R: 20/21/22 Harmful by inhalation, in contact with skin and if swallowed.  | 
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN | 
| 419825-250MG | 04055977187847 | 
Documentation
Hh Signaling Antagonist X, Itraconazole - CAS 84625-61-6 - Calbiochem SDS
| Title | 
|---|
Hh Signaling Antagonist X, Itraconazole - CAS 84625-61-6 - Calbiochem Certificates of Analysis
| Title | Lot Number | 
|---|---|
| 419825 | 
References
| Reference overview | 
|---|
| Kim, J., et al. 2010. Cancer Cell 17, 388. | 



  
